In the BioHarmony Drug Report Database

"Preview" Icon

Stiripentol

Diacomit (stiripentol) is a small molecule pharmaceutical. Stiripentol was first approved as Diacomit on 2007-01-03. It is used to treat seizures in the USA. It has been approved in Europe to treat juvenile myoclonic epilepsy.

 

Trade Name

 

Diacomit
 

Common Name

 

stiripentol
 

ChEMBL ID

 

CHEMBL1983350
 

Indication

 

juvenile myoclonic epilepsy, seizures
 

Drug Class

 

Image (chem structure or protein)

Stiripentol structure rendering